Greenwich LifeSciences, Inc.GLSINASDAQ
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
68.24%
↑ 20% above average
Average (7y)
56.91%
Historical baseline
Range
High:236.56%
Low:-59.42%
Volatility
520.1%
High variability
| Period | Value |
|---|---|
| 2024 | 68.24% |
| 2023 | 18.89% |
| 2022 | 81.93% |
| 2021 | 236.56% |
| 2020 | -59.42% |
| 2019 | 105.23% |
| 2018 | 3.84% |
| 2017 | 0.00% |